These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9197178)

  • 1. The role of the IGF-I receptor in apoptosis.
    Baserga R; Resnicoff M; D'Ambrosio C; Valentinis B
    Vitam Horm; 1997; 53():65-98. PubMed ID: 9197178
    [No Abstract]   [Full Text] [Related]  

  • 2. The IGF-I receptor in cell growth, transformation and apoptosis.
    Baserga R; Hongo A; Rubini M; Prisco M; Valentinis B
    Biochim Biophys Acta; 1997 Jun; 1332(3):F105-26. PubMed ID: 9196021
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the insulin-like growth factor I receptor in transformation and apoptosis.
    Resnicoff M; Baserga R
    Ann N Y Acad Sci; 1998 Apr; 842():76-81. PubMed ID: 9599296
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors.
    Grothey A; Voigt W; Schöber C; Müller T; Dempke W; Schmoll HJ
    J Cancer Res Clin Oncol; 1999; 125(3-4):166-73. PubMed ID: 10235470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
    Rubin R; Baserga R
    Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I receptor signalling in transformation and differentiation.
    Valentinis B; Baserga R
    Mol Pathol; 2001 Jun; 54(3):133-7. PubMed ID: 11376123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dominant negative IGF-I receptor ].
    Adachi Y; Min Y; Yamamoto H; Imai K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():500-4. PubMed ID: 14574944
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression.
    Werner H
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):1-5. PubMed ID: 9723878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
    D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
    Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The IGF-I receptor: a new antiproliferative marker?].
    Fehmann HC; Staats P; Göke B
    Z Gastroenterol; 1995 Oct; 33(10):630-1. PubMed ID: 7502562
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and malignant transformation: two roads diverged in a wood.
    Baserga R; Morrione A
    J Cell Biochem; 1999; Suppl 32-33():68-75. PubMed ID: 10629105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.
    Wang Y; Sun Y
    Curr Cancer Drug Targets; 2002 Sep; 2(3):191-207. PubMed ID: 12188907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin-like growth factor I receptor: a key to tumor growth?
    Baserga R
    Cancer Res; 1995 Jan; 55(2):249-52. PubMed ID: 7812953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.
    Zhao H; Dupont J; Yakar S; Karas M; LeRoith D
    Oncogene; 2004 Jan; 23(3):786-94. PubMed ID: 14737113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.
    Prager D; Li HL; Asa S; Melmed S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2181-5. PubMed ID: 8134369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.